Ping-Ching Hsu, PhD

Research Program: Cancer Prevention and Population Sciences Faculty Rank: Associate Professor Campus: University of Arkansas for Medical Sciences College: College of Public Health Department: Environmental Health Sciences

Cancer Research Interest

• Disease Site Focus: Breast, Prostate
• Research Focus Area: Health Disparities, Prevention, Treatment, Informatics, Diagnosis/ Prognosis
• Type of Research: Population Sciences

Contact Information

• Email Address: PHSU@UAMS.EDU
• Profiles Research Networking Software: View Profile

Active Grants

• US Department of Defense – HT94252310924
  “Modulation effect of folate on the association between inorganic arsenic and aggressive prostate cancer”
  Principal Investigator
  9/1/2023 – 8/31/2026
• Arkansas Breast Cancer Research Program – AWD00055865
  “ABCRP Fy24 award - Ping-ching, Hsu”
  Principal Investigator
  9/1/2023 – 8/31/2025
• NIH/Nat. Inst. of General Medical Sciences – 2P20GM109005
  “Metabolic Phenotypes Of Doxorubicin-Induced Cardiotoxicity in Breast Cancer”
  Principal Investigator
  8/17/2020 – 5/31/2025

Recent Publications

• Ellis ET, Fairman BJ, Stahr SD, [et al., including Hsu PC]. Cigarette smoking and prostate cancer aggressiveness among African and European American men. Cancer causes & control : CCC. 2024. PMID: 38758522. PMCID: PMC11377453.
• Tu SM, Chen JZ, Singh SR, [et al., including Hsu PC]. Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics. Cancers. 2024 16(3). PMID: 38339375. PMCID: PMC10854810.
• Broeckling CD, Beger RD, Cheng LL, [et al., including Hsu PC]. Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples. Analytical chemistry. 2023. PMID: 38055671. PMCID: PMC10753522.
• Ellis ET, Bauer MA, Beck JT, [et al., including Hsu PC]. Increased Utilization of Low-Dose Computed Tomography for Lung Cancer Screening at an Arkansas Community Oncology Clinic. Journal of the American College of Radiology : JACR. 2023. PMID: 37984767. PMCID: PMC11102528.
• Singh A, Kinnebrew G, Hsu PC, [et al.]. Untargeted Metabolomics and Body Mass in Adolescents: A Cross-Sectional and Longitudinal Analysis. Metabolites. 2023 13(8). PMID: 37623843. PMCID: PMC10456720.
• Hsu PC, Daughters SB, Bauer MA, [et al.]. Association of DNA methylation signatures with cognitive performance among smokers and ex-smokers. Tobacco induced diseases. 2023 21:106. PMID: 37605769. PMCID: PMC10405227.
• Addicott MA, Sutfin EL, Reynolds LM, [et al., including Hsu PC]. Biochemical validation of self-reported electronic nicotine delivery system and tobacco heaviness of use. Experimental and clinical psychopharmacology. 2022. PMID: 36107700. PMCID: PMC10184506.
• Su LJ, Young SG, Collins J, [et al., including Hsu PC]. Geospatial Assessment of Pesticide Concentration in Ambient Air and Colorectal Cancer Incidence in Arkansas, 2013-2017. International journal of environmental research and public health. 2022 19(6). PMID: 35328946. PMCID: PMC8951132.
• Hsu PC, Maity S, Patel J, [et al.]. Metabolomics Signatures and Subsequent Maternal Health among Mothers with a Congenital Heart Defect-Affected Pregnancy. Metabolites. 2022 12(2). PMID: 35208175. PMCID: PMC8877777.
• Qi S, Fu Z, Wu L, [et al., including Hsu PC]. Cognition, Aryl Hydrocarbon Receptor Repressor Methylation, and Abstinence Duration-Associated Multimodal Brain Networks in Smoking and Long-Term Smoking Cessation. Frontiers in neuroscience. 2022 16:923065. PMID: 35968362. PMCID: PMC9363622.
• Bauer MA, Todorova VK, Stone A, [et al., including Hsu PL]. Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer. Cancers. 2021 13(24). PMID: 34944912. PMCID: PMC8699582.
• Matich EK, Laryea JA, Seely KA, [et al., including Hsu PC]. Association between pesticide exposure and colorectal cancer risk and incidence: A systematic review. Ecotoxicology and environmental safety. 2021 219:112327. PMID: 34029839. PMCID: PMC8694176.
• Evans AM, O'Donovan C, Playdon M, [et al., including Hsu PC]. Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners. Metabolomics : Official journal of the Metabolomic Society. 2020 16(10):113. PMID: 33044703. PMCID: PMC7641040.
• Hsu PC, Kadlubar SA, Siegel ER, [et al.]. Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer. PloS one. 2020 15(4):e0230248. PMID: 32298288. PMCID: PMC7162481.
• Hernandez Puente CV, Hsu PC, Rogers LJ, [et al.]. Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study. Frontiers in oncology. 2020 10:879. PMID: 32582547. PMCID: PMC7290046.
• Todorova VK, Hsu PC, Wei JY, [et al.]. Biomarkers of inflammation, hypercoagulability and endothelial injury predict early asymptomatic doxorubicin-induced cardiotoxicity in breast cancer patients. American journal of cancer research. 2020 10(9):2933-2945. PMID: 33042627. PMCID: PMC7539772.